Search research articles
Contact Us
Filters
Showing results (31-40 of 68) with videos related to
Page
of 7
Sort By:
Cancer Research
|
July 5, 2005
Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread
Goutham Narla, Analisa DiFeo, Shen Yao, et al.
The Lancet Regional Health. Europe
|
August 13, 2025
Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association
Manon Allaire, Leonardo G Da Fonseca, Marco Sanduzzi-Zamparelli, et al.
Molecular Metabolism
|
April 9, 2023
The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326
Brian E Ford, Shruti S Chachra, Katrina Rodgers, et al.
Journal of Hepatology
|
August 28, 2013
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica Dyson, Bryan Jaques, Dipankar Chattopadyhay, et al.
International Journal of Cancer
|
July 17, 2015
High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers
Barry M Dent, Laura F Ogle, Rachel L O'Donnell, et al.
British Journal of Cancer
|
November 11, 2017
Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
Jane Margetts, Laura F Ogle, Stephen L Chan, et al.
Gastroenterology
|
April 2, 2004
Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer
Helen L Reeves, Goutham Narla, Olagunju Ogunbiyi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2014
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival
Liam Cornell, Joanne M Munck, Clara Alsinet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2014
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade
Philip J Johnson, Sarah Berhane, Chiaki Kagebayashi, et al.
Cancers
|
July 14, 2023
Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study
Shuell De Souza, Jeffrey Kahol de Jong, Ylenia Perone, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 68) with videos related to
Sort By:
Page
of 7
Cancer Research
|
July 5, 2005
Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread
Goutham Narla, Analisa DiFeo, Shen Yao, et al.
The Lancet Regional Health. Europe
|
August 13, 2025
Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association
Manon Allaire, Leonardo G Da Fonseca, Marco Sanduzzi-Zamparelli, et al.
Molecular Metabolism
|
April 9, 2023
The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326
Brian E Ford, Shruti S Chachra, Katrina Rodgers, et al.
Journal of Hepatology
|
August 28, 2013
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica Dyson, Bryan Jaques, Dipankar Chattopadyhay, et al.
International Journal of Cancer
|
July 17, 2015
High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers
Barry M Dent, Laura F Ogle, Rachel L O'Donnell, et al.
British Journal of Cancer
|
November 11, 2017
Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
Jane Margetts, Laura F Ogle, Stephen L Chan, et al.
Gastroenterology
|
April 2, 2004
Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer
Helen L Reeves, Goutham Narla, Olagunju Ogunbiyi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2014
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival
Liam Cornell, Joanne M Munck, Clara Alsinet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2014
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade
Philip J Johnson, Sarah Berhane, Chiaki Kagebayashi, et al.
Cancers
|
July 14, 2023
Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study
Shuell De Souza, Jeffrey Kahol de Jong, Ylenia Perone, et al.
Page
of 7